‘Cipla to invest Rs 600 cr in R&D’ – Business Standard News

0

Pharma major Cipla on Wednesday said it would spend around Rs 600 crore in research and development during this year to implement research oriented projects.

“Innovation is an integral part of Cipla’s success in R&D. This year we will spend around Rs 600 crore in R&D and efforts are directed towards accountable and implementable research- oriented projects,” Cipla Chairman Y K Hamied told shareholders at the company’s 78th Annual General Meeting.

“We have been granted many patents in the field of pharmaceuticals,” he added.

Read more – Business Standard News

 

share >>>
September 4, 2014 |

Leave a Reply

Vantage Theme – Powered by WordPress.
Skip to toolbar